Close

Novavax (NVAX) Announces Positive Data from Three Studies of its Vaccine Against South African Strain

Go back to Novavax (NVAX) Announces Positive Data from Three Studies of its Vaccine Against South African Strain
Novavax, Inc. (NASDAQ: NVAX) Delayed: 4.78 -0.07 (1.44%)
Previous Close $4.85    52 Week High $9.23 
Open $4.84    52 Week Low $1.16 
Day High $4.79    P/E N/A 
Day Low $4.76    EPS $-0.30 
Volume 3,599,522